Davis R M Inc Biogen Inc. Transaction History

Davis R M Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 18, 2019	SELL	$278.5 - $352.75 $341,719 - $432,824	-1,227 Closed	0 $0
Q3 2018 Oct 17, 2018	SELL	$293.51 - $383.83 $857,929 - $1.12 Million	-2,923 Reduced 70.43%	1,227 $434,000
Q2 2018 Jul 19, 2018	BUY	$257.52 - $306.91 $780,285 - $929,937	3,030 Added 270.54%	4,150 $1.2 Million
Q1 2018 Apr 19, 2018	SELL	$260.13 - $367.91 $1,560 - $2,207	-6 Reduced 0.53%	1,120 $307,000
Q4 2017 Jan 16, 2018	BUY	$307.64 - $344.58 $58,451 - $65,470	190 Added 20.3%	1,126 $359,000
Q3 2017 Oct 24, 2017	BUY	$281.15 - $329.69 $263,156 - $308,589	936	936 $293,000

1,036

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Davis R M Inc, based on Form 13F filings with the SEC.

Stay updated on Davis R M Inc with notifications on news.